Patents by Inventor Maria Lopez-Bresnahan

Maria Lopez-Bresnahan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20200155477
    Abstract: The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy.
    Type: Application
    Filed: February 5, 2020
    Publication date: May 21, 2020
    Inventors: H. JAMES BRENTZEL, JR., MARIA LOPEZ-BRESNAHAN, NAZIH AMMOURY
  • Cladribine regimen for treating multiple sclerosis
    Patent number: 10555913
    Abstract: The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: February 11, 2020
    Assignee: MERCK SERONO SA
    Inventors: H. James Brentzel, Jr., Maria Lopez-Bresnahan, Nazih Ammoury
  • CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20180207109
    Abstract: The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy.
    Type: Application
    Filed: March 22, 2018
    Publication date: July 26, 2018
    Inventors: H. JAMES BRENTZEL, Jr., MARIA LOPEZ-BRESNAHAN, NAZIH AMMOURY
  • Cladribine regimen for treating multiple sclerosis
    Patent number: 9925151
    Abstract: The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: March 27, 2018
    Assignee: MERCK SERONO SA
    Inventors: H. James Brentzel, Jr., Maria Lopez-Bresnahan, Nazih Ammoury
  • Cladribine regimen for treating multiple sclerosis
    Patent number: 8377903
    Abstract: The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: February 19, 2013
    Assignee: Merck Serono SA
    Inventors: Giampiero De Luca, Arnaud Ythier, Alain Munafo, Maria Lopez-Bresnahan
  • Cladribine Regimen for Treating Multiple Sclerosis
    Publication number: 20100203017
    Abstract: The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.
    Type: Application
    Filed: April 23, 2010
    Publication date: August 12, 2010
    Applicant: Merck Serono S.A.
    Inventors: Giampiero De Luca, Arnaud Ythier, Alain Munafo, Maria Lopez-Bresnahan
  • Cladribine regimen for treating multiple sclerosis
    Patent number: 7713947
    Abstract: The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be orally administered and wherein re-treatments are possible.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: May 11, 2010
    Assignee: Merck Serono S.A.
    Inventors: Giampiero De Luca, Arnaud Ythier, Alain Munafo, Maria Lopez-Bresnahan
  • CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20100021429
    Abstract: The present invention relates to the use of multiple doses of Cladribine combined with beta interferon for the treatment of multiple sclerosis in patients who are refractory to at least one conventional therapy.
    Type: Application
    Filed: May 23, 2007
    Publication date: January 28, 2010
    Applicant: LABORATORIES SERONO SA
    Inventors: H. James Brentzel, JR., Maria Lopez-Bresnahan, Nazih Ammoury